SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-123246
Filing Date
2021-10-05
Accepted
2021-10-05 18:17:04
Documents
1
Period of Report
2021-10-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2129291-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2129291-1_4seq1.xml 4 3855
  Complete submission text file 0001104659-21-123246.txt   5244
Mailing Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032
Business Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Issuer) CIK: 0001614067 (see all company filings)

IRS No.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FORTY SEVEN, INC. 1490 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address
Gibbs Craig S (Reporting) CIK: 0001614856 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38630 | Film No.: 211308114